aspirin
Cisplatin Resources
1. M. H. Hanigan and P. Devarajan, “Cisplatin nephrotoxicity: molecular mechanisms,” Cancer Therapy, vol. 1, pp. 47–61, 2003.
2. Santiago Gómez-Ruiz, Danijela Maksimović-Ivanić, Sanja Mijatović, and Goran N. Kaluđerović, “On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy,”Bioinorganic Chemistry and Applications, vol. 2012, Article ID 140284, 14 pages, 2012.
3. N/A
4. Santiago Gómez-Ruiz, Danijela Maksimović-Ivanić, Sanja Mijatović, and Goran N. Kaluđerović, “On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy,”Bioinorganic Chemistry and Applications, vol. 2012, Article ID 140284, 14 pages, 2012.
5. Comparative Chemogenomics To Examine the Mechanism of Action of DNA-Targeted Platinum-Acridine Anticancer Agents
Kahlin Cheung-Ong, Kyung Tae Song, Zhidong Ma, Daniel Shabtai, Anna Y. Lee, David Gallo, Lawrence E. Heisler, Grant W. Brown, Ulrich Bierbach, Guri Giaever, and Corey Nislow
ACS Chemical Biology Article ASAP
6. Ishida S, Lee J, Thiele DJ, Herskowitz I (2002) Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci. 99, 14298–14302.
Comparative Chemogenomics To Examine the Mechanism of Action of DNA-Targeted Platinum-Acridine Anticancer Agents
Kahlin Cheung-Ong, Kyung Tae Song, Zhidong Ma, Daniel Shabtai, Anna Y. Lee, David Gallo, Lawrence E. Heisler, Grant W. Brown, Ulrich Bierbach, Guri Giaever, and Corey Nislow
ACS Chemical Biology Article ASAP
7. Leonardo Meneghin Mendonça, Carla da Silva Machado, Cristiane Cardoso Correia Teixeira, Luis Alexandre Pedro de Freitas, Maria de Lourdes Pires Bianchi, Lusânia Maria Greggi Antunes, Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells, NeuroToxicology, Available online 1 October 2012, ISSN 0161-813X, 10.1016/j.neuro.2012.09.011.
1. M. H. Hanigan and P. Devarajan, “Cisplatin nephrotoxicity: molecular mechanisms,” Cancer Therapy, vol. 1, pp. 47–61, 2003.
2. Santiago Gómez-Ruiz, Danijela Maksimović-Ivanić, Sanja Mijatović, and Goran N. Kaluđerović, “On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy,”Bioinorganic Chemistry and Applications, vol. 2012, Article ID 140284, 14 pages, 2012.
3. N/A
4. Santiago Gómez-Ruiz, Danijela Maksimović-Ivanić, Sanja Mijatović, and Goran N. Kaluđerović, “On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy,”Bioinorganic Chemistry and Applications, vol. 2012, Article ID 140284, 14 pages, 2012.
5. Comparative Chemogenomics To Examine the Mechanism of Action of DNA-Targeted Platinum-Acridine Anticancer Agents
Kahlin Cheung-Ong, Kyung Tae Song, Zhidong Ma, Daniel Shabtai, Anna Y. Lee, David Gallo, Lawrence E. Heisler, Grant W. Brown, Ulrich Bierbach, Guri Giaever, and Corey Nislow
ACS Chemical Biology Article ASAP
6. Ishida S, Lee J, Thiele DJ, Herskowitz I (2002) Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci. 99, 14298–14302.
Comparative Chemogenomics To Examine the Mechanism of Action of DNA-Targeted Platinum-Acridine Anticancer Agents
Kahlin Cheung-Ong, Kyung Tae Song, Zhidong Ma, Daniel Shabtai, Anna Y. Lee, David Gallo, Lawrence E. Heisler, Grant W. Brown, Ulrich Bierbach, Guri Giaever, and Corey Nislow
ACS Chemical Biology Article ASAP
7. Leonardo Meneghin Mendonça, Carla da Silva Machado, Cristiane Cardoso Correia Teixeira, Luis Alexandre Pedro de Freitas, Maria de Lourdes Pires Bianchi, Lusânia Maria Greggi Antunes, Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells, NeuroToxicology, Available online 1 October 2012, ISSN 0161-813X, 10.1016/j.neuro.2012.09.011.